Biocon, Zentiva get EU approval for generic diabetes, weight management drug

Biocon Ltd and Zentiva have secured decentralised procedure approval in the EU for Liraglutide, a complex formulation used for diabetes and weight management. This approval targets the generic versions of Novo Nordisk's Victoza and Saxenda, authorising their use in multiple EU member states simultaneously.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/pRT79gW
via IFTTT